These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 15865075

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Phase I-II study of irinotecan hydrochloride combined with cisplatin in patients with advanced gastric cancer.
    Shirao K, Shimada Y, Kondo H, Saito D, Yamao T, Ono H, Yokoyama T, Fukuda H, Oka M, Watanabe Y, Ohtsu A, Boku N, Fujii T, Oda Y, Muro K, Yoshida S.
    J Clin Oncol; 1997 Mar; 15(3):921-7. PubMed ID: 9060529
    [Abstract] [Full Text] [Related]

  • 3. Phase I study of radical thoracic radiation, weekly irinotecan, and cisplatin in locally advanced non-small cell lung carcinoma.
    Langer CJ, Somer R, Litwin S, Feigenberg S, Movsas B, Maiale C, Sherman E, Millenson M, Nicoloau N, Huang C, Treat J.
    J Thorac Oncol; 2007 Mar; 2(3):203-9. PubMed ID: 17410043
    [Abstract] [Full Text] [Related]

  • 4. A phase II study of dose-intensified weekly concomitant administration of cisplatin and irinotecan in chemonaive patients with extensive-disease small-cell lung cancer.
    Han JY, Lee DH, Lee SY, Park CG, Kim HY, Kim EA, Yoon SM, Lee HG, Lee JS.
    Med Oncol; 2005 Mar; 22(3):281-90. PubMed ID: 16110139
    [Abstract] [Full Text] [Related]

  • 5. A novel combination of cisplatin, irinotecan, and capecitabine in patients with advanced cancer.
    Jefford M, Michael M, Rosenthal MA, Davis ID, Green M, McClure B, Smith J, Waite B, Zalcberg J.
    Invest New Drugs; 2004 Apr; 22(2):185-92. PubMed ID: 14739668
    [Abstract] [Full Text] [Related]

  • 6. Biweekly irinotecan and cisplatin as second-line chemotherapy in pretreated patients with advanced gastric cancer: a multicenter phase II study.
    Baek JH, Kim JG, Sohn SK, Kim DH, Lee KB, Song HS, Kwon KY, Do YR, Ryoo HM, Bae SH, Park KU, Kim MK, Lee KH, Hyun MS, Chung HY, Yu W.
    J Korean Med Sci; 2005 Dec; 20(6):966-70. PubMed ID: 16361806
    [Abstract] [Full Text] [Related]

  • 7. Preliminary study of fortnightly irinotecan hydrochloride plus cisplatin therapy in patients with advanced gastric and colorectal cancer.
    Sato A, Kurihara M, Matsukawa M, Shimada K, Yamazaki T, Nakamachi M, Koda T.
    Cancer Chemother Pharmacol; 2001 May; 47(5):380-4. PubMed ID: 11391851
    [Abstract] [Full Text] [Related]

  • 8. Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study.
    Jagasia MH, Langer CJ, Johnson DH, Yunus F, Rodgers JS, Schlabach LL, Cohen AG, Shyr Y, Carbone DP, Devore RF.
    Clin Cancer Res; 2001 Jan; 7(1):68-73. PubMed ID: 11205920
    [Abstract] [Full Text] [Related]

  • 9. Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trial.
    Di Bartolomeo M, Buzzoni R, Mariani L, Ferrario E, Katia D, Gevorgyan A, Zilembo N, Bordonaro R, Bochicchio AM, Massidda B, Ardizzoia A, Marini G, Aitini E, Schieppati G, Comella G, Pinotti G, Palazzo S, Cicero G, Bajetta E, Italian Trial in Medical Oncology (ITMO) Group, Villa E, Fagnani D, Reguzzoni G, Agostana B, Oliani C, Kildani B, Duro M, Botta M, Mozzana R, Mantovani G.
    Oncology; 2006 Jan; 71(5-6):341-6. PubMed ID: 17855795
    [Abstract] [Full Text] [Related]

  • 10. Phase I study of weekly alternating therapy with irinotecan/cisplatin and etoposide/cisplatin for patients with small-cell lung cancer.
    Johnson FM, Kurie JM, Peeples BO, Lee JJ, Feng L, Pisters KM, Fossella FV, Papadimitrakopoulou VA, Blumenschein GR, Komaki R, Glisson BS.
    Clin Lung Cancer; 2003 Jul; 5(1):40-5. PubMed ID: 14596703
    [Abstract] [Full Text] [Related]

  • 11. Phase I evaluation of continuous 5-fluorouracil infusion followed by weekly paclitaxel in patients with advanced or recurrent gastric cancer.
    Kondo K, Kobayashi M, Kojima H, Hirabayashi N, Kataoka M, Araki K, Matsui T, Takiyama W, Miyashita Y, Nakazato H, Nakao A, Sakamoto J.
    Jpn J Clin Oncol; 2005 Jun; 35(6):332-7. PubMed ID: 15961435
    [Abstract] [Full Text] [Related]

  • 12. Phase I/II study of 3-week combination of S-1 and cisplatin chemotherapy for metastatic or recurrent gastric cancer.
    Lee JL, Kang HJ, Kang YK, Ryu MH, Chang HM, Kim TW, Sohn HJ, Kim H, Lee JS.
    Cancer Chemother Pharmacol; 2008 Apr; 61(5):837-45. PubMed ID: 17579864
    [Abstract] [Full Text] [Related]

  • 13. A phase II trial of weekly fractionated irinotecan and cisplatin for advanced gastric cancer.
    Jeung HC, Rha SY, Noh SH, Roh JK, Chung HC.
    Cancer Chemother Pharmacol; 2007 Feb; 59(3):313-20. PubMed ID: 16770582
    [Abstract] [Full Text] [Related]

  • 14. Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer.
    Ilson DH, Bains M, Kelsen DP, O'Reilly E, Karpeh M, Coit D, Rusch V, Gonen M, Wilson K, Minsky BD.
    J Clin Oncol; 2003 Aug 01; 21(15):2926-32. PubMed ID: 12885811
    [Abstract] [Full Text] [Related]

  • 15. Phase I study of irinotecan and S-1 combination therapy in patients with metastatic gastric cancer.
    Yamada Y, Yasui H, Goto A, Arai T, Ura T, Hamaguchi T, Muro K, Shimada Y, Shirao K.
    Int J Clin Oncol; 2003 Dec 01; 8(6):374-80. PubMed ID: 14663640
    [Abstract] [Full Text] [Related]

  • 16. A phase II study of irinotecan in combination with cisplatin as second-line chemotherapy in patients with metastatic or locally advanced gastric cancer.
    Shen WC, Yang TS, Hsu HC, Chen JS.
    Chang Gung Med J; 2011 Dec 01; 34(6):590-8. PubMed ID: 22196061
    [Abstract] [Full Text] [Related]

  • 17. Phase I clinical and pharmacologic study of weekly cisplatin combined with weekly irinotecan in patients with advanced solid tumors.
    Saltz LB, Spriggs D, Schaaf LJ, Schwartz GK, Ilson D, Kemeny N, Kanowitz J, Steger C, Eng M, Albanese P, Semple D, Hanover CK, Elfring GL, Miller LL, Kelsen D.
    J Clin Oncol; 1998 Dec 01; 16(12):3858-65. PubMed ID: 9850031
    [Abstract] [Full Text] [Related]

  • 18. Phase I/II study of irinotecan, 5-fluorouracil, and l-leucovorin combination therapy (modified Saltz regimen) in patients with metastatic colorectal cancer.
    Goto A, Yamada Y, Hosokawa A, Ura T, Arai T, Hamaguchi T, Muro K, Shimada Y, Shirao K.
    Int J Clin Oncol; 2004 Oct 01; 9(5):364-8. PubMed ID: 15549585
    [Abstract] [Full Text] [Related]

  • 19. Irinotecan/cisplatin in advanced, treated gastric or gastroesophageal junction carcinoma.
    Ajani JA, Baker J, Pisters PW, Ho L, Mansfield PF, Feig BW, Charnsangavej C.
    Oncology (Williston Park); 2002 May 01; 16(5 Suppl 5):16-8. PubMed ID: 12109800
    [Abstract] [Full Text] [Related]

  • 20. Phase I trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancer.
    Tew WP, Radovich D, O'Reilly E, Schwartz G, Schrag D, Saltz LB, Kelsen DP, Kepler S, Ilson DH.
    Invest New Drugs; 2009 Aug 01; 27(4):366-73. PubMed ID: 18956138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.